Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA consolidated 'Locations' section has been added listing California, New York, and Oregon, replacing the previous separate location headings; the revision note indicates v3.3.3.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a new revision label v3.3.2 added and the previous v3.3.1 removed, indicating a minor update to the document. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.1 is now displayed on the page, replacing the previous v3.2.0.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding status notice banner was removed from the Study Details page (NCT03278626). Core trial information, eligibility criteria, and study plan remain unchanged.SummaryDifference0.4%

- Check60 days agoChange DetectedNo significant changes detected on the page; the study title, details, eligibility criteria, and listed locations appear unchanged. The content is visually similar to the previous version with no additions or deletions affecting user actions.SummaryDifference0.4%

- Check89 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.